US Military Ammunition Expenditure

Aspen Neuroscience Prices IPO at $15 at Low End

Aspen Neuroscience (ASPE), a clinical-stage biotechnology company developing stem cell therapies for Parkinson's disease, priced its initial public offering at…

Operation Epic Fury: The $11 Billion Price Tag of US Air Superiority

A new report from the Center for Strategic and International Studies (CSIS) has pulled back the curtain on the staggering…